Untitled Document
     

 

FOR IMMEDIATE RELEASE

August 15, 2003

INTEGRA Holdings AG has announced the successful completion of the reorganisation of its INTEGRA Biosciences AG business.

INTEGRA Holdings AG announces successful completion of INTEGRA Biosciences reorganisation ...

INTEGRA Holdings AG has announced the successful completion of the reorganisation of its INTEGRA Biosciences AG business.

This announcement is subsequent to the statement in December 2002, that the board of directors had decided for INTEGRA Biosciences AG to focus upon its core competences in the development, production and marketing of tools and instruments for daily routine lab tasks in life sciences laboratories.

INTEGRA Biosciences have achieved, within a tight timescale, a series of notable changes enabling the business to move strongly forward in the first seven months of 2003.

Only two months after the formal decision and announcement of the corporate reorganisation the R&D, production and marketing / sales departments were successfully integrated into INTEGRA Biosciences' facility in Chur, Switzerland.

Following the strategy of focusing and strengthening its lab instruments business, INTEGRA Biosciences' former subsidiaries in Germany, France, Switzerland and the USA all became independent and have successfully started to operate under new ownership. The German and French companies have continued to operate under the name of INTEGRA Biosciences. In Switzerland and the US the distribution activities have been taken over by Vitaris AG and Argos Technologies Inc. respectively. In the UK all distribution activities have been successfully transferred to Scientific Laboratory Supplies. All these major territories have reported a positive development of sales in the first half of 2003 reflecting their ability to fully concentrate efforts on distribution to end users.

Following the successful integration of the sample storage sales and marketing department into its operation in Lelystad, Netherlands, INTEGRA Biosciences' announced at the end of June 2003 that the majority of the shares of Micronic BV had been subject to a management buy out. Micronic is continuing to distribute and serve INTEGRA Biosciences products in the Netherlands.

On the occasion of ACHEMA 2003 in May 2003, INTEGRA Biosciences presented their first new products in their liquid handling range since the announcement of their reorganisation in December. The introduction of the PIPETBOY comfort - a lightweight serological pipette and the VACUSAFE comfort - an aspiration system for the safe and comfortable removal of critical fluids in the laboratories. With these new products INTEGRA Biosciences is well positioned to strengthen its already strong market position in this market segment. Other new products are scheduled for launch before the year-end.

With the completed structural changes as well as the consequent concentration on the development, production and marketing of laboratory tools and instruments for the daily routine lab tasks, INTEGRA Biosciences AG is well positioned for growth in the global life science markets.


CONTACTS:

Worldwide HQ

INTEGRA Biosciences
CHUR, Switzerland

Tel: + 41 81 286 9530
Email: info@integra-biosciences.com
www.integra-biosciences.com